Dose-related differences in effectiveness of human papillomavirus vaccination against genital warts: a nationwide study of 550 000 young girls

M Blomberg, C Dehlendorff, C Sand… - Clinical Infectious …, 2015 - academic.oup.com
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

[PDF][PDF] Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls

M Blomberg, C Dehlendorff, C Sand, SK Kjaer - 2015 - researchgate.net
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

[PDF][PDF] Dose-related differences in effectiveness of HPV vaccination against genital warts: a nationwide study of 550,000 young girls

M Blomberg, C Dehlendorff, C Sand, SK Kjaer - 2015 - Citeseer
In this nationwide study, measurement of dose-related protection by HPV vaccination
against genital warts showed that three vaccinations are required for maximal protection …

[PDF][PDF] Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls

M Blomberg, C Dehlendorff, C Sand… - Clinical Infectious …, 2015 - scholar.archive.org
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls

M Blomberg, C Dehlendorff… - … diseases: an official …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls.

M Blomberg, C Dehlendorff, C Sand… - Clinical Infectious …, 2015 - search.ebscohost.com
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.

M Blomberg, C Dehlendorff, C Sand… - … Infectious Diseases: an …, 2015 - europepmc.org
Background Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls Publikation …

ikm.ku.dk
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-related differences in effectiveness of human papillomavirus vaccination against genital warts: a nationwide study of 550 000 young girls.

M Blomberg, C Dehlendorff, C Sand, SK Kjaer - 2015 - cabidigitallibrary.org
Background. Reducing the number of doses in the human papillomavirus (HPV) vaccination
regimen from 3 to 2 could increase coverage rates. In this cohort study, we assessed the risk …

Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls

M Blomberg, C Dehlendorff, C Sand… - … infectious diseases: an …, 2015 - research.regionh.dk
BACKGROUND: Reducing the number of doses in the human papillomavirus (HPV)
vaccination regimen from 3 to 2 could increase coverage rates. In this cohort study, we …